- Leukemia
- Liver Cancer
- Lung Cancer
- Lung Cancer – Non-Small Cell
- Lung Cancer – Small Cell
- Lymphoma
- Melanoma
- Mesothelioma
- Miscellaneous
- Multiple Myeloma
- Myelodysplastic Syndrome
- Neuroblastoma
- Non-Hodgkin’s Lymphoma
- Aggressive/Intermediate Grade Non-Hodgkin’s Lymphoma
- Follicular Lymphoma
- Highly Aggressive/High Grade Non-Hodgkin’s Lymphoma
- Indolent/Low Grade Non-Hodgkin’s Lymphoma
- Mantle Cell Non-Hodgkin’s Lymphoma
- Recurrent Non-Hodgkin’s Lymphoma
- Screening/Prevention Non-Hodgkin’s Lymphoma
- T-Cell Non-Hodgkin’s Lymphoma
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rectal Cancer
- Renal Cancer
- Retinoblastoma
- Sarcoma
- Skin Cancer
- Supportive Care
- Management and Prevention of Anemia Supportive Care
- Management and Prevention of Anorexia and Weight Loss Supportive Care
- Management and Prevention of Bone Complications Supportive Care
- Management and Prevention of Fatigue Supportive Care
- Management and Prevention of Mucositis Supportive Care
- Management and Prevention of Nausea and Vomiting Supportive Care
- Management and Prevention of Neutropenia Supportive Care
- Management and Prevention of Thrombocytopenia Supportive Care
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Uterine Cancer
- Vaginal Cancer
Cancer News
Early Treatment in Smoldering Myeloma Improves Long-Term Outcomes
(02/03/2017)
Use of the treatment combination consisting of Revlimid (lenalidomide) plus dexamethasone during smoldering myeloma appears to significantly improve long-term outcomes for patients. These results were published in The Lancet Oncology, and presented at the 2016 annual meeting of the American Society of Hematology (ASH). Smoldering myeloma is considered to be a pre-cancerous condition, in which …
Continue reading "Early Treatment in Smoldering Myeloma Improves Long-Term Outcomes"